Artificial intelligence in correctional health care—designing for access, inclusion, and trust
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-Oct-2026 17:16 ET (31-Oct-2026 21:16 GMT/UTC)
Modern therapies have transformed care for people with multiple sclerosis (MS). Yet the disease continues to progress in a substantial proportion of patients, even in the absence of relapses. Detecting and treating this gradual worsening of disability remains one of the greatest challenges in MS care. Researchers from the University of Basel, Switzerland, now report on a blood marker that could help track disease progression and monitor treatment response.
Lindsay A. Farrer, PhD, chief of biomedical genetics at Boston University Chobanian & Avedisian School of Medicine, has been selected as the recipient of a 3-year, $450,000 Zenith Fellows Award from the Alzheimer’s Association for his project, “Genes to AD Therapy: A Roadmap for Personalized Medicine.” Zenith Fellows Awards are among the most prestigious in Alzheimer's research worldwide.
VCU Massey Comprehensive Cancer Center was recently awarded a $2.7 million Worta McCaskill-Stevens K12 grant from the National Institutes of Health (NIH). The five-year grant will allow Massey to mentor promising, multidisciplinary, early-stage clinical investigators in the conception, development, and implementation of innovative cancer prevention and control studies designed to optimize participation by cancer survivors and individuals most at risk for cancer throughout Virginia.VCU Massey Comprehensive Cancer Center was recently awarded a $2.7 million Worta McCaskill-Stevens K12 grant from the National Institutes of Health (NIH). The five-year grant will allow Massey to mentor promising, multidisciplinary, early-stage clinical investigators in the conception, development, and implementation of innovative cancer prevention and control studies designed to optimize participation by cancer survivors and individuals most at risk for cancer throughout Virginia.